Gain a solid foundation for your manufacturing process, mitigate risks and ensure compliance. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in domestic and overseas manufacturing to exchange ideas on best practice and share case studies on innovation within the area.

Conference Coverage: Additives Manufacturing Summit

Contributor: Chanice Henry
Posted: 7/7/2015

Conference Coverage: Additives Manufacturing Summit - Chanice Henry

Approximately 20% of the global additive manufacturing market is devoted to healthcare usage. An area that has been earmarked for rapid growth. Located in Kensington. London, industry professionals and decision makers gathered for the only additive manufacturing forum dedicated to medicine and dentistry to discuss breaking the boundaries of modern medicine through 3D Innovation. Full Article »

Events related to this topic:

Defining a Criteria for Disposable Solutions in Biomanufacturing - Chris Shaw

In this interview Chris Shaw, CMO at Benchmark Vaccines, discusses the primary criteria for finding a disposable solution for biomanufacturing. Shaw also talks about the industry-wide challenges selecting a disposable solution, such as balancing flexibility and cost. Full Video »

Events related to this topic:

What Pharma can Learn from the Food & Beverage Industry- An Interview with Pepsico's Steve Hills - Gerald Clarke

The pharma industry has a lot to learn from the food and beverage industry when it comes to contract manufacturing. To get to grips with this outsider's view, we spoke with Steve Hills, European Contract Manufacturing Director at Pepsico. Steve outlines where companies can go wrong in working with CMOs Full Podcast »

Events related to this topic:

Creating Effective Leachables and Extractables Testing: Whose Responsibility Is It? - Eric Langer

The problem of leachables and extractables (L&E) in single-use devices continues to hound both suppliers and end-users, and remains one of the more challenging issues inhibiting regulatory acceptance of single-use devices. Full Column »

Events related to this topic:

Serialisation: Top Tech Integration Considerations

Roger Bate from the American Enterprise Institute estimates that global economy is hit by $10 billion in losses due to counterfeit and substandard medicines alone. Life loss, he estimates, equates to around 100,000 deaths a year – primarily felt by emerging markets. These two costs are part of what sparked the introduction of serialisation – the method of tracing the lifecycle of the medicine via a serial number. Full Whitepaper »

Events related to this topic:

Advertise With Us

Join the Pharmas IQ Community